Gastric cancer is one of the malignant tumors with high global incidence and mortality rates, and its main precancerous disease is chronic atrophic gastritis. Atrophic gastritis is a chronic gastritis characterized by a reduction or disappearance of gastric mucosal glands, which may be accompanied by decreased gastric acid secretion and decreased digestive function. Long term development may increase the risk of gastric cancer.

We are committed to:‌Identifying disease causes‌ and developing preventive strategies；Implementing comprehensive treatments‌, including: Helicobacter pylori eradication, integrated traditional Chinese and Western medicine to reverse gastric precancerous lesions and alleviate symptoms;‌Conducting regular monitoring‌ for early detection of early-stage gastric cancer.